Literature DB >> 17042035

Cervical length in women in preterm labor with intact membranes: relationship to intra-amniotic inflammation/microbial invasion, cervical inflammation and preterm delivery.

R-M Holst1, B Jacobsson, H Hagberg, U-B Wennerholm.   

Abstract

OBJECTIVE: Intra-amniotic infection, diagnosed by microbial invasion of the amniotic cavity (MIAC) and/or the presence of intra-amniotic inflammation (IAI), is related to adverse perinatal outcome in women with preterm labor. Due to the subclinical nature of IAI, a correct diagnosis depends on amniocentesis, which is an invasive method not performed as a clinical routine. The aim of this study was to evaluate if cervical length measured by transvaginal sonography could assist in the identification of women at high risk for IAI.
METHODS: Cervical length was assessed by transvaginal sonography in 87 women with singleton pregnancies in preterm labor (<34 weeks of gestation). Cervical (n=87) and amniotic (n=55) fluids were collected. Polymerase chain reactions for Ureaplasma urealyticum and Mycoplasma hominis, and culture for aerobic and anaerobic bacteria, were performed. Interleukin (IL)-6 and IL-8 were analyzed by enzyme-linked immunosorbent assay.
RESULTS: IAI was present in 25/55 (45%) of the patients presenting with preterm labor who underwent amniocentesis. Women with IAI had a significantly shorter cervical length (median, 10 (range, 0-34) mm) than had those without IAI (median, 21 (range, 11-43) mm) (P<0.0001). Receiver-operating characteristics curve analysis showed that a cervical length (cut-off of 15 mm) predicted IAI (relative risk, 3.6; CI, 1.9-10.0) with a sensitivity of 72%, specificity of 83%, positive predictive value of 78% and negative predictive value of 78%. Cervical length was also significantly associated with preterm birth up to 7 days from sampling and at <or=34 weeks.
CONCLUSION: Cervical length assessed by transvaginal sonography predicts IAI as well as preterm birth and could thereby be a useful clinical tool in the management of patients in preterm labor. Copyright (c) 2006 ISUOG.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17042035     DOI: 10.1002/uog.3837

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  17 in total

1.  Sterile intra-amniotic inflammation in asymptomatic patients with a sonographic short cervix: prevalence and clinical significance.

Authors:  Roberto Romero; Jezid Miranda; Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Francesca Gotsch; Zhong Dong; Ahmed I Ahmed; Bo Hyun Yoon; Sonia S Hassan; Chong J Kim; Steven J Korzeniewski; Lami Yeo; Yeon Mee Kim
Journal:  J Matern Fetal Neonatal Med       Date:  2014-09-24

2.  A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra-amniotic infection in preterm labor with intact membranes.

Authors:  Roberto Romero; Jezid Miranda; Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Francesca Gotsch; Zhong Dong; Ahmed I Ahmed; Bo Hyun Yoon; Sonia S Hassan; Chong Jai Kim; Steven J Korzeniewski; Lami Yeo
Journal:  Am J Reprod Immunol       Date:  2014-01-13       Impact factor: 3.886

3.  Change in cervical length in cases resulting in threatened preterm labor.

Authors:  Toshiyuki Yoshizato; Hiroshi Tsujioka; Shinji Horiuchi; Kyoko Shirota; Hirotsugu Obama; Takeshi Nojiri; Fusanori Yotsumoto; Shingo Miyamato
Journal:  J Med Ultrason (2001)       Date:  2010-08-07       Impact factor: 1.314

Review 4.  Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis.

Authors:  Agustin Conde-Agudelo; Roberto Romero; Kypros Nicolaides; Tinnakorn Chaiworapongsa; John M O'Brien; Elcin Cetingoz; Eduardo da Fonseca; George Creasy; Priya Soma-Pillay; Shalini Fusey; Cetin Cam; Zarko Alfirevic; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2012-11-15       Impact factor: 8.661

Review 5.  Additional effects of the cervical length measurement in women with preterm contractions: a systematic review.

Authors:  Jolande Y Vis; Rosanna A Kuin; William A Grobman; Ben Willem J Mol; Patrick M M Bossuyt; Brent C Opmeer
Journal:  Arch Gynecol Obstet       Date:  2011-04-12       Impact factor: 2.344

6.  The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women.

Authors:  Roberto Romero; Sonia S Hassan; Pawel Gajer; Adi L Tarca; Douglas W Fadrosh; Lorraine Nikita; Marisa Galuppi; Ronald F Lamont; Piya Chaemsaithong; Jezid Miranda; Tinnakorn Chaiworapongsa; Jacques Ravel
Journal:  Microbiome       Date:  2014-02-03       Impact factor: 14.650

7.  The vaginal microbiota of pregnant women who subsequently have spontaneous preterm labor and delivery and those with a normal delivery at term.

Authors:  Roberto Romero; Sonia S Hassan; Pawel Gajer; Adi L Tarca; Douglas W Fadrosh; Janine Bieda; Piya Chaemsaithong; Jezid Miranda; Tinnakorn Chaiworapongsa; Jacques Ravel
Journal:  Microbiome       Date:  2014-05-27       Impact factor: 14.650

8.  Evaluating the use of the QUiPP app and its impact on the management of threatened preterm labour: A cluster randomised trial.

Authors:  Helena A Watson; Naomi Carlisle; Paul T Seed; Jenny Carter; Katy Kuhrt; Rachel M Tribe; Andrew H Shennan
Journal:  PLoS Med       Date:  2021-07-06       Impact factor: 11.069

9.  Intra-amniotic infection/inflammation as a risk factor for subsequent ruptured membranes after clinically indicated amniocentesis in preterm labor.

Authors:  Sung Youn Lee; Kyo Hoon Park; Eun Ha Jeong; Kyung Joon Oh; Aeli Ryu; Ahra Kim
Journal:  J Korean Med Sci       Date:  2013-07-31       Impact factor: 2.153

Review 10.  A New, Potent, and Placenta-Permeable Macrolide Antibiotic, Solithromycin, for the Prevention and Treatment of Bacterial Infections in Pregnancy.

Authors:  Jeffrey A Keelan; Matthew S Payne; Matthew W Kemp; Demelza J Ireland; John P Newnham
Journal:  Front Immunol       Date:  2016-04-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.